Full Text View
Tabular View
Study Results
Related Studies
Vorinostat in Treating Patients With Relapsed or Refractory Advanced Hodgkin's Lymphoma
This study has been completed.
Study NCT00132028   Information provided by National Cancer Institute (NCI)

First Received on August 16, 2005.   Last Updated on May 7, 2014   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
More general drug interventions related to this trial
Sponsors listed in this trial